Electronic standardized assessment tools like PainCAS can be an integral part of a solution that can help to document opioid risk, which can potentially help to guide appropriate opioid prescribing and increase documentation in patients’ medical records.
Palm Springs, CA (PRWEB) May 15, 2015
The Pain Management Center at Brigham and Women’s Hospital, recipient of the 2015 American Pain Society Clinical Center of Excellence Award, presented how an electronic online clinical tool for assessing pain and opioid risk in chronic pain patients had positive impact on the documentation of opioid risk stratification and treatment planning at the American Pain Society’s 34th Annual Scientific Meeting taking place May 13-16 at the Palm Springs Convention Center. Researchers from Brigham and Women’s Hospital presented this information in a scientific poster titled “Use of an Electronic Pain Assessment and Opioid Risk Assessment Program to Promote Reporting and Benefit Treatment among Chronic Pain Patients.” This poster was a collaborative effort, created in partnership with Inflexxion, Inc., which developed the tool with funding from the National Institutes of Health.
Inflexxion created the tool, the PainCAS: Clinical Assessment System® to help reduce variability in pain assessment, which is often the foundation of developing a pain treatment plan. The tool is also intended to facilitate communication between patients and healthcare providers by providing a streamlined and standardized patient assessment process. By replacing traditional paper-and-pencil assessments, one of the goals of PainCAS is to improve workflow related to administration and documentation of pain and opioid risk assessments. The scientific poster presentation supported how the use of PainCAS increased the likelihood of a documented opioid risk assessment and opioid risk management plan in patients’ medical records, which has potentially beneficial implications for improving quality and consistency of patient care.
“Electronic standardized assessment tools like PainCAS can be an integral part of a solution that can help to document opioid risk, which can potentially help to guide appropriate opioid prescribing and increase documentation in patients’ medical records,” says Robert N. Jamison, PhD, Chief Psychologist at the Pain Management Center at Brigham and Women’s Hospital and Professor at Harvard Medical School in the Departments of Anesthesia and Psychiatry.
PainCAS captures demographic information, pain assessment, and quality-of-life variables, and contains validated electronic versions of the Screener and Opioid Assessment for Patients with Pain (SOAPP®) and the Current Opioid Misuse Measure (COMM®), which help to assess the likelihood of aberrant drug-related behaviors. PainCAS generates reports for healthcare providers that present the pertinent positives from the patient assessment in a visually intuitive manner, while giving a graphical overview of treatment progress. Reports for patients are generated in an easy-to-read report card format, keeping the patient informed and engaged in treatment.
About Inflexxion, Inc.
Founded in 1989, Inflexxion develops scientifically based, interactive technologies and collects data in innovative ways through clinical settings, Internet WebCrawler technology, and web-surveys regarding health status, health behaviors, health beliefs, and health outcomes. Partners and customers rely on Inflexxion for online programs that reduce health-related risks, enhance clinical outcomes, and positively influence quality of care. Inflexxion analyzes and disseminates health-related data for purposes of surveillance, risk management, epidemiological studies, quality improvement, and outcome measurement used by healthcare organizations and regulatory authorities to help improve care and inform public policy. Through education, Inflexxion changes behaviors by providing online, empirically driven, health-related approaches to healthcare providers, patients, and the general population in the areas of addiction and recovery, pain management, and prescription drug safety. For more information please visit http://www.inflexxion.com.